Melalloc AD Cream – Product Overview

Melalloc AD Cream is a prescription‑grade topical medication that combines two proven acne‑treating actives, Mequinol 2 % and Tretinoin 0.025 %, within a 15 g tube. Produced by Ajanta Pharma Ltd, the product is specifically formulated for the management of acne vulgaris in adult patients. Its dual‑ingredient strategy targets both the inflammatory and non‑inflammatory components of the disease, offering a comprehensive approach to clearing existing lesions and preventing future breakouts.

What is Melalloc AD Cream?

Melalloc AD Cream belongs to the class of topical retinoids and antiseborrheic agents. Mequinol acts as a mild anti‑inflammatory and keratolytic component that helps to unblock pores and reduce the size of sebaceous follicles, while Tretinoin modulates epidermal differentiation and sebum production by binding to retinoic acid receptors in the skin. The synergistic effect of these two ingredients provides a two‑pronged mechanism: Mequinol reduces follicular plugging and bacterial colonisation, whereas Tretinoin accelerates the turnover of skin cells, replacing damaged cells with healthier ones. This combination makes Melalloc AD Cream an effective option for patients who have not responded adequately to single‑agent therapies.

Uses and Benefits

The therapeutic uses of Melalloc AD Cream extend beyond simple lesion reduction. Clinically, it is indicated for:

• Treatment of moderate to severe facial acne, including papules, pustules, and comedones.
• Reduction of inflammatory lesions and the prevention of new breakouts.
• Improvement of overall skin texture, tone, and clarity.
• Mitigation of post‑inflammatory hyperpigmentation that can persist after acne resolves.
• Long‑term maintenance therapy to keep acne under control after initial clearance.

Patients typically observe a noticeable decrease in the number of visible lesions after four to six weeks of consistent use. With continued application, the reduction can reach 60‑70 % of baseline lesions by the third month. In addition, many users report smoother skin and a more even complexion, which can enhance self‑esteem and quality of life. The formulation is designed for once‑daily application, making it convenient for integration into a regular skincare routine.

How It Works

The efficacy of Melalloc AD Cream stems from the complementary mechanisms of its two active ingredients:

1. Mequinol 2 %: This agent functions as a mild anti‑inflammatory and keratolytic agent. It reduces the viscosity of sebum, facilitating the expulsion of follicular plugs, and it also exhibits modest antibacterial activity against Propionibacterium acnes, helping to lower the microbial load on the skin surface.
2. Tretinoin 0.025 %: As a first‑generation retinoid, Tretinoin binds to nuclear retinoic acid receptors in keratinocytes, influencing gene expression that regulates cell proliferation and differentiation. This leads to a faster shedding of the stratum corneum, preventing the formation of comedonal blockages and promoting the growth of new, healthier tissue.

Together, these actions result in a reduction of both inflammatory and non‑inflammatory acne lesions, a decrease in lesion severity, and an overall improvement in skin appearance. The dual‑action also helps to prevent the development of resistance that can occur with single‑agent therapies.

Dosage Guidelines

For optimal results, apply a thin, even layer of Melalloc AD Cream to the cleaned and dried affected areas of the face once daily, preferably in the evening. The recommended amount is enough to cover the treatment zone without excess; a pea‑size quantity is usually sufficient for the entire face. The medication should be left on the skin overnight and washed off in the morning if irritation becomes pronounced. If the skin becomes overly dry or irritated, reduce application to every other night and gradually increase frequency as tolerance improves. It is important to avoid applying the cream to the lips, eyes, or mucous membranes, and to keep the product away from broken skin or open wounds.

Side Effects

Most patients experience only mild, transient side effects, which typically diminish with continued use. Common reactions include:

• Mild erythema (redness) and a sensation of warmth shortly after application.
• Peeling or flaking of the outer skin layer.
• Dryness or a feeling of tightness.
• Occasional burning or stinging during the first few applications.

Less common but more serious adverse reactions may include severe contact dermatitis, intense irritation, or an allergic response. Should any of these occur, discontinue use immediately and seek medical advice. In rare cases, prolonged use may lead to changes in skin pigmentation; if this is observed, a healthcare professional should be consulted.

Warnings and Precautions

Melalloc AD Cream is intended for external use only and should be kept out of reach of children. Patients with a known hypersensitivity to Mequinol, Tretinoin, or any inactive ingredients must avoid the product. Pregnant or breastfeeding women should consult a physician before initiating therapy, as the safety of systemic absorption during these periods has not been fully established. The cream should not be used concurrently with other strong topical acne agents (e.g., benzoyl peroxide or salicylic acid) without medical guidance, as this may increase the risk of irritation. Individuals with pre‑existing skin conditions such as eczema, rosacea, or psoriasis should discuss potential interactions with a dermatologist. Store the tube at room temperature, away from moisture and direct heat, and avoid exposing it to excessive sunlight.

Frequently Asked Questions

1. How long does it take to see results with Melalloc AD Cream? Clinical studies and real‑world usage indicate that most users notice a reduction in inflammatory lesions within two to four weeks of consistent nightly application. Maximum improvement is typically observed after eight to twelve weeks, at which point many patients achieve a 60‑70 % reduction in lesion count compared with baseline.
2. Can I use Melalloc AD Cream with oral acne medications? Yes, but only under the supervision of a qualified healthcare professional. Combining topical and oral therapies can enhance efficacy, yet it also raises the potential for skin irritation. Your dermatologist can tailor the regimen to balance effectiveness and tolerability.
3. Is Melalloc AD Cream suitable for sensitive skin? While the formulation is designed for adult skin, individuals with highly sensitive or reactive skin should introduce the product gradually. Starting with a reduced frequency (e.g., every other night) and monitoring for signs of irritation can help determine tolerance before moving to nightly use.
4. Does Melalloc AD Cream cause sun sensitivity? Tretinoin can increase photosensitivity, making the skin more vulnerable to UV damage. Patients are strongly advised to apply a broad‑spectrum sunscreen with a minimum SPF of 30 during daylight hours and to limit prolonged sun exposure while using the product.
5. Can I apply makeup over Melalloc AD Cream? It is recommended to allow the cream to fully absorb into the skin for about 20‑30 minutes before applying any cosmetics. This waiting period reduces the likelihood of worsening irritation and ensures that the active ingredients have adequate contact time with the skin.

For additional prescribing information, refer to the official product label or consult a dermatologist. More comprehensive guidance on acne management can be found through reputable sources such as the National Institutes of Health and the U.S. Food and Drug Administration.

Related Products

• Aziderm Cream 10% (Azelaic Acid)
• Mytret Micro Gel 0.04 (Tretinoin)
• Ajanta ED Trial Pack (Sildenafil/Tadalafil/Vardenafil)ED Trial Pack
• Acnedap Gel (Dapsone)
• Adaferin Gel (Adapalene)
• Adapen Gel (Adapalene)
• Erytop Gel (Clindamycin)
• Ivrea Cream (Ivermectin)
• Melacare Cream (Hydroquinone/Tretinoin/Mometasone)
• Persol AC Gel (Benzoyl Peroxide)
• Retino A Cream (Tretinoin)
• Retino A Micro Gel (Tretinoin)